As a recognized leader in the contract research organization (CRO) industry for conducting complex cardiology and cardiovascular trials, PharPoint Research has contributed expert services critical to the approval of many important cardiovascular drugs. PharPoint Research has participated in 40 cardiology studies in every phase and many indications, including atrial fibrillation, long QT syndrome, chronic angina, and pulmonary hypertension. Our significant cardiology therapeutic experience encompasses 17 cardiology indications. We have provided biostatistics and data management services for dozens of these cardiology trials. PharPoint is a full service CRO that provides support for clinical trials at every level and phase. Our network of best in class expertise allows us to provide an accomplished service for cardiology studies of all types.
About the Author
Expanded Consulting Services
We recently expanded our consulting services in response to a growing need from clients. Read the full release here.